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. The resulting mixture was refluxed for 4.5 h, and then concentrated under reduced pressure. The crude material was dissolved again in MeOH, treated with Amberlist A-21, and the solvent was evaporated to dryness. Pure 3 (265 mg) was obtained in 50% yield after purification through flash column chromatography EtOAc -Petr. ether 1:1, Rf = 0.37). (Found: C, 63.52; H, 7.23; N, 5.12. C 14 H 19 NO 4 requires C, 63.38; H, 7.22; N, 5.28%) . [α] 25 D +45.6 (c = 1.2, CHCl 3 ). δ H (200 MHz, CDCl 3 ) 7. 48-7.46 (m, 2H), 7.39-7.32 (m, 3H), 3.97-3.93 (m, 1H) 
4-[2(S)-(9H-Fluoren-9-ylmethoxycarbonylamino)-3-methyl-butyryl]-3,4-dihydro-2H-[1,4]oxazine-3(R)-carboxylic acid methyl ester (5).
Morpholine compound 1b (100 mg, 0.57 mmol) was dissolved in anhydrous CH 2 Cl 2 (2 mL), then 2,6-lutidine (133 µL, 1.14 mmol) and
Fmoc-(L)-Val (245 mg, 0.69 mmol) were added. The reaction mixture was brought to 60 °C and stirred for 2 h under a nitrogen atmosphere. The reaction mixture was then diluted with CH 2 Cl 2 and sequentially washed with 5% HCl, 5% NaHCO 3 and brine. The organic layers were dried over Na 2 SO 4 , filtered and evaporated to give a brownish foam. Then, toluene (10 mL) and pTsOH (180 S6 mg, 0.91 mmol) were added, and the mixture was refluxed over molecular sieves for 2 h. Then, the mixture was diluted with EtOAc (20 mL) and sequentially washed with 5% HCl, 5% NaHCO 3 and brine. The organic layers were dried over Na 2 SO 4 , filtered and evaporated to give pure 5 after flash 162.5, 161.8, 143.3, 141.3, 127.8, 127.5, 127.1, 125.0, 124.9, 124.8, 124.5, 124.3, 124.1, 120.0, 114.3, 113.9, 109.7, 108.8, 68.0, 67.8, 67.7, 67.6, 52.6, 47.2, 31.9, 30.0, 22.7, 19 .1 ppm. ESI-MS m/z 465.3 (M + +1). Compounds 6 and 7 were obtained from compound 1a (100 mg, 0.57 mmol) and Fmoc-α-Me-AlaCl (217 mg, 0.63 mmol) following the general procedure A in 41% and 35% yields, respectively, after flash chromatography purification (1:1 EtOAc/petr. ether, 6: R f = 0.11, 7: R f = 0.09). 6: , 52.88; H, 7.12; N, 12.01. C 10 
6,6-Dimethyl-5-oxo-hexahydro-oxazolo[3,2-a]pyrazine-3-carboxylic acid methyl ester (31).
Compound 31 was obtained as a mixture of inseparable diastereomers from morpholine 1b (100 mg, 0.57 mmol) and Fmoc-α-Me-Ala-Cl (217 mg, 0.63 mmol) according to general procedure C in 57% yield, after flash chromatographic purification (EtOAc/petr. Compound 42 (50 mg, 0.14 mmol) was dissolved in a minimal amount of CH 2 Cl 2 , then toluene (10 mL)and acid silica gel (20 mg) were added and the mixture was refluxed over 4Å molecular sieves for 30 min. Then, the mixture was filtered over NaHCO 3 , and the solvent was evaporated to give S21 pure 46 in 92% yield. (Found: C, 60.65; H, 5.78; N, 8.73. C 16 Table S2 . Crystal data and structure refinement for exp_259.
ESI-MS m/z 229.2 (M + +1). (3S,6S,8aR/S)-6-Isobutyl-5-oxo-hexahydro-oxazolo[3,2-a]pyrazine-3-carboxylic acid methyl ester (32 and 33). Compounds
Identification code exp_259
Empirical formula C32 H40 N4 O8
Formula weight 608.68 86 (2) 69 (2) 52 (2) -20(1) (4) 90 ( 
